Article info
Ovarian Cancer
Does Significant Medical Comorbidity Negate the Benefit of Up-front Cytoreduction in Advanced Ovarian Cancer?
- Address correspondence and reprint requests to James Stuart Ferriss, MD, Temple University School of Medicine, 3401 N Broad St, 7 OPB, Philadelphia, PA 19140. E-mail: jferriss@temple.edu.
Citation
Does Significant Medical Comorbidity Negate the Benefit of Up-front Cytoreduction in Advanced Ovarian Cancer?
Publication history
- Received October 31, 2011
- First published June 1, 2012.
Online issue publication
February 26, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2012 by IGCS and ESGO